- Home
- TDOC vs SVRA Comparison
TDOC vs SVRA Comparison
Compare TDOC & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TDOC | SVRA |
|---|---|---|
| Founded | 2002 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | TDOC | SVRA |
|---|---|---|
| Price | $7.70 | $6.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 8 |
| Target Price | ★ $9.54 | $6.88 |
| AVG Volume (30 Days) | ★ 5.5M | 3.1M |
| Earning Date | 10-29-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,528,199,000.00 | N/A |
| Revenue This Year | $0.13 | N/A |
| Revenue Next Year | $1.09 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.35 | $1.89 |
| 52 Week High | $15.21 | $6.98 |
Technical Indicators
Market Signals| Indicator | TDOC | SVRA |
|---|---|---|
| Relative Strength Index (RSI) | 51.46 | 80.81 |
| Support Level | $7.41 | $5.55 |
| Resistance Level | $7.84 | $6.98 |
| Average True Range (ATR) | 0.26 | 0.45 |
| MACD | 0.08 | 0.10 |
| Stochastic Oscillator | 84.69 | 96.44 |
Price Performance
Historical ComparisonAbout TDOC Teladoc Health Inc.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.